Roivant Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 9, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Cap	20,895	19,954	7,022	8,502	5,610	3,433
Market Cap Growth	169.39%	184.16%	-17.41%	51.56%	63.40%	-46.12%
Enterprise Value	16,710	16,523	2,725	2,532	4,812	2,050
Last Close Price	29.05	27.70	10.09	10.54	7.38	4.94
PE Ratio	-	-	-	2.02	-	-
PS Ratio	2529.64	2415.71	241.70	259.91	91.54	62.10
PB Ratio	4.62	4.41	1.50	1.42	4.85	2.07
P/TBV Ratio	4.45	4.25	1.56	1.47	4.54	2.00
EV/Sales Ratio	2023.05	2000.39	93.80	77.41	78.52	37.08
EV/EBITDA Ratio	-	-	-	0.56	-	-
EV/EBIT Ratio	-	-	-	0.56	-	-
Debt / Equity Ratio	0.02	0.02	0.02	0.01	0.27	0.13
Debt / EBITDA Ratio	-	-	-	0.01	-	-
Net Debt / Equity Ratio	-0.92	-0.92	-1.02	-1.08	-1.03	-1.07
Net Debt / EBITDA Ratio	8.18	8.18	4.84	-1.42	1.03	1.32
Net Debt / FCF Ratio	5.52	5.52	5.67	8.40	1.40	2.56
Asset Turnover	0.00	0.00	0.00	0.01	0.02	0.02
Quick Ratio	18.00	18.00	32.71	24.35	6.15	11.18
Current Ratio	18.37	18.37	33.47	25.24	6.60	11.64
Return on Equity (ROE)	-7.75%	-7.59%	-12.54%	112.87%	-67.05%	-44.82%
Return on Assets (ROA)	-14.17%	-13.90%	-16.97%	93.13%	-47.45%	-52.26%
Return on Invested Capital (ROIC)	-89.37%	-97.12%	-200.44%	698.00%	-210.89%	-274.55%
Return on Capital Employed (ROCE)	-9.81%	-9.61%	-16.39%	99.13%	-52.03%	-56.65%
Earnings Yield	-	-	-	49.62%	-	-
Buyback Yield / Dilution	4.35%	4.35%	12.71%	-16.59%	-6.43%	-6.30%
Total Shareholder Return	4.35%	4.35%	12.71%	-16.59%	-6.43%	-6.30%

SEC Filings: 10-K · 10-Q